Pharmacy

Guidance for hospital and clinical-based pharmacies as well as regulations related to commercial pharmacies.
One item that stood out in the HPC’s meeting last week was the ever-increasing price of insulin.
The Health Policy Commission in coming months is scheduled to decide on whether the state’s healthcare cost growth benchmark – currently set at 3.1% – should remain at that level.
As the Massachusetts House and Senate begin to construct their FY2020 budget proposals, MHA, in consultation with its members, is calling attention to a series of priorities.
Safe injection facilities (SIFs) – a location where people can inject illicit drugs under the supervision of trained staff – are on two distinct paths in the state.
The 2018 Cost Trends Report from the Health Policy Commission released last month showed the persistent growth in prescription drug spending over the state’s healthcare cost growth benchmark.
Several new Massachusetts policies are aiding the collective fight against the opioid epidemic.
Last year, an insurance company denied life insurance coverage to a Boston Medical Center (BMC) nurse because she included Narcan on her application’s medication list.
Last week the top federal law enforcement official in the state wrote a Boston Globe op-ed in which he essentially said, don’t even think about opening a SIF.
The American Hospital Association (AHA) last week laid out its 2019 public policy agenda.
Governor Charlie Baker last Wednesday released a $42.7 billion FY2020 state budget proposal that among other things maintains level MassHealth provider reimbursement rates,
The American Hospital Association released a report last week showing that total drug spending per hospital admission increased 18.5% between FYs 2015 and 2017.
Last week, Sen. Bernie Sanders (I-Vermont), along with several Democratic Senate and House members, including House Oversight Committee Chairman Elijah Cummings (D-Md.), announced the release of three bills intended to lower drug prices.
Boston Medical Center Grayken Center for Addiction, and DPH’s Bureau of Substance Addiction Services are sponsoring free buprenorphine “x-waiver” trainings across the state.
A U.S. District Court has issued a permanent injunction to CMS, halting the federal government’s nearly 30% reduction in reimbursements to certain hospital outpatient departments purchasing drugs through the 340B program.
MHA has released guidelines to assist hospitals develop appropriate programs to administer and/or prescribe Medication for Addiction Treatment in their EDs or satellite emergency facilities.
As 2019 begins, here are a few key developments that should occur.
The Board of Registration in Pharmacy’s much anticipated regulations on how a pharmacy can conduct sterile compounding will have unintended consequences that will increase costs and disrupt patient care.
DPH recently released a notice outlining new requirements for providers prescribing benzodiazepines.
In Mass., optimism over a federal opioid bill is mixed with concern over an impending threat to the state's behavioral health system
The American Hospital Association last week announced 340B drug program “good stewardship principles.”

Resources

Click on the links below for easy access to important information related to state healthcare issues and advocacy.
Visit the Commonwealth of Massachusetts websites below to find information on legislative hearings and other meetings of interest to the healthcare community.
To guide your navigation of the legislative process and assist your advocacy efforts, please visit the following state websites:
MHA has also developed the following documents for your information and benefit: